Format

Send to

Choose Destination
Nat Rev Microbiol. 2008 Jan;6(1):17-27.

The biology and future prospects of antivirulence therapies.

Author information

1
Department of Molecular Microbiology, Washington University, Saint Louis, Missouri 63110, USA.

Erratum in

  • Nat Rev Microbiol. 2009 Nov;7(11):836.

Abstract

The emergence and increasing prevalence of bacterial strains that are resistant to available antibiotics demand the discovery of new therapeutic approaches. Targeting bacterial virulence is an alternative approach to antimicrobial therapy that offers promising opportunities to inhibit pathogenesis and its consequences without placing immediate life-or-death pressure on the target bacterium. Certain virulence factors have been shown to be potential targets for drug design and therapeutic intervention, whereas new insights are crucial for exploiting others. Targeting virulence represents a new paradigm to empower the clinician to prevent and treat infectious diseases.

PMID:
18079741
PMCID:
PMC2211378
DOI:
10.1038/nrmicro1818
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center